|
1.
|
Collins RA, Ng TB, Fong WP, Wan CC and
Yeung HW: A comparison of human immunodeficiency virus type 1
inhibition by partially purified aqueous extracts of Chinese
medicinal herbs. Life Sci. 60:PL345–PL351. 1997. View Article : Google Scholar
|
|
2.
|
Hu CQ, Chen K, Shi Q, Kilkuskie RE, Cheng
YC and Lee KH: Anti-AIDS agents, 10.
Acacetin-7-O-beta-D-galactopyranoside, an anti-HIV principle from
Chrysanthemum morifolium and a structure-activity
correlation with some related flavonoids. J Nat Prod. 57:42–51.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Sassi AB, Harzallah-Skhiri F, Bourgougnon
N and Aouni M: Antimicrobial activities of four Tunisian
Chrysanthemum species. Indian J Med Res. 127:183–192.
2008.PubMed/NCBI
|
|
4.
|
Liu Q, Liu H, Yuan Z, Wei D and Ye Y:
Evaluation of antioxidant activity of chrysanthemum extracts and
tea beverages by gold nanoparticles-based assay. Colloids Surf B
Biointerfaces. 92:348–352. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
He J, Chen F, Chen S, Lv G, Deng Y, Fang
W, Liu Z, Guan Z and He C: Chrysanthemum leaf epidermal surface
morphology and antioxidant and defense enzyme activity in response
to aphid infestation. J Plant Physiol. 168:687–693. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Marongiu B, Piras A, Porcedda S, Tuveri E,
Laconi S, Deidda D and Maxia A: Chemical and biological comparisons
on super-critical extracts of Tanacetum cinerariifolium
(Trevir) Sch. Bip with three related species of chrysanthemums of
Sardinia (Italy). Nat Prod Res. 23:190–199. 2009.PubMed/NCBI
|
|
7.
|
Wu TY, Khor TO, Saw CL, Loh SC, Chen AI,
Lim SS, Park JH, Cai L and Kong AN:
Anti-inflammatory/anti-oxidative stress activities and differential
regulation of Nrf2-mediated genes by non-polar fractions of tea
Chrysanthemum zawadskii and licorice Glycyrrhiza
uralensis. AAPS J. 13:1–13. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Seo JY, Lim SS, Park J, Lim JS, Kim HJ,
Kang HJ, Yoon Park JH and Kim JS: Protection by Chrysanthemum
zawadskii extract from liver damage of mice caused by carbon
tetrachloride is maybe mediated by modulation of QR activity. Nutr
Res Pract. 4:93–98. 2010.
|
|
9.
|
Robertson RP, Harmon J, Tran PO, Tanaka Y
and Takahashi H: Glucose toxicity in beta-cells: type 2 diabetes,
good radicals gone bad, and the glutathione connection. Diabetes.
52:581–587. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Robertson RP: Chronic oxidative stress as
a central mechanism for glucose toxicity in pancreatic islet beta
cells in diabetes. J Biol Chem. 279:42351–42354. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
López-Ibarra PJ, Pastor MM,
Escobar-Jiménez F, Pardo MD, González AG, Luna JD, Requena ME and
Diosdado MA: Bone mineral density at time of clinical diagnosis of
adult-onset type 1 diabetes mellitus. Endocr Pract. 7:346–351.
2001.PubMed/NCBI
|
|
12.
|
Tuominen JT, Impivaara O, Puukka P and
Ronnemaa T: Bone mineral density in patients with type 1 and type 2
diabetes. Diabetes Care. 22:1196–1200. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Herskind AM, Christensen K,
Nørgaard-Andersen K and Andersen JF: Diabetes mellitus and healing
of closed fractures. Diabete Metab. 18:63–64. 1992.PubMed/NCBI
|
|
14.
|
Bai XC, Lu D, Bai J, Zheng H, Ke ZY, Li XM
and Luo SQ: Oxidative stress inhibits osteoblastic differentiation
of bone cells by ERK and NF-kappaB. Biochem Biophys Res Commun.
314:197–207. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Fatokun AA, Stone TW and Smith RA:
Hydrogen peroxide-induced oxidative stress in MC3T3-E1 cells: The
effects of glutamate and protection by purines. Bone. 39:542–551.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Seeman E: Reduced bone formation and
increased bone resorption: rational targets for the treatment of
osteoporosis. Osteoporos Int. 14(Suppl 3): S2–S8. 2003.PubMed/NCBI
|
|
17.
|
Thornalley P, Wolff S, Crabbe J and Stern
A: The autoxidation of glyceraldehyde and other simple
monosaccharides under physiological conditions catalysed by buffer
ions. Biochim Biophys Acta. 797:276–287. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Kaneto H, Fujii J, Myint T, Miyazawa N,
Islam KN, Kawasaki Y, Suzuki K, Nakamura M, Tatsumi H, Yamasaki Y
and Taniguchi N: Reducing sugars trigger oxidative modification and
apoptosis in pancreatic beta-cells by provoking oxidative stress
through the glycation reaction. Biochem J. 320:855–863.
1996.PubMed/NCBI
|
|
19.
|
Bunn HF and Higgins PJ: Reaction of
monosaccharides with proteins: possible evolutionary significance.
Science. 213:222–224. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Koh G, Suh KS, Chon S, Oh S, Woo JT, Kim
SW, Kim JW and Kim YS: Elevated cAMP level attenuates
2-deoxy-D-ribose-induced oxidative damage in pancreatic beta-cells.
Arch Biochem Biophys. 438:70–79. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Koh G, Lee DH and Woo JT: 2-Deoxy-D-ribose
induces cellular damage by increasing oxidative stress and protein
glycation in a pancreatic beta-cell line. Metabolism. 59:325–332.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Lee YJ, Suh KS, Choi MC, Chon S, Oh S, Woo
JT, Kim SW, Kim JW and Kim YS: Kaempferol protects HIT-T15
pancreatic beta cells from 2-deoxy-D-ribose-induced oxidative
damage. Phytother Res. 24:419–423. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Suh KS, Oh S, Woo JT, Kim SW, Kim JW, Kim
YS and Chon S: Apigenin attenuates 2-deoxy-D-ribose-induced
oxidative cell damage in HIT-T15 pancreatic β-cells. Biol Pharm
Bull. 35:121–216. 2012.PubMed/NCBI
|
|
24.
|
Choi EM and Kim YH: Hesperetin attenuates
the highly reducing sugar-triggered inhibition of osteoblast
differentiation. Cell Biol Toxicol. 24:225–231. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Lee KH and Choi EM: Myricetin, a naturally
occurring flavonoid, prevents 2-deoxy-D-ribose induced dysfunction
and oxidative damage in osteoblastic MC3T3-E1 cells. Eur J
Pharmacol. 591:1–6. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Suh KS, Choi EM, Kwon M, Chon S, Oh S, Woo
JT, Kim SW, Kim JW and Kim YS: Kaempferol attenuates
2-deoxy-D-ribose-induced oxidative cell damage in MC3T3-E1
osteoblastic cells. Biol Pharm Bull. 32:746–749. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Kanno S, Anuradha CD and Hirano S:
Localization of zinc after in vitro mineralization in osteoblastic
cells. Biol Trace Elem Res. 83:39–47. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Suh KS, Chon S, Oh S, Kim SW, Kim JW, Kim
YS and Woo JT: Prooxidative effects of green tea polyphenol
(-)-epigallocate-chin-3-gallate on the HIT-T15 pancreatic beta cell
line. Cell Biol Toxicol. 26:189–199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Balint E, Szabo P, Marshall CF and Sprague
SM: Glucose-induced inhibition of in vitro bone mineralization.
Bone. 28:21–28. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Terada M, Inaba M, Yano Y, Hasuma T,
Nishizawa Y, Morii H and Otani S: Growth-inhibitory effect of a
high glucose concentration on osteoblast-like cells. Bone.
22:17–23. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Han SH, Sung KH, Yim DS, Lee SK, Lee CK,
Ha NJ and Kim KJ: The effect of linarin on LPS-induced cytokine
production and nitric oxide inhibition in murine macrophages cell
line RAW264.7. Arch Pharm Res. 25:170–177. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Clifford MN, Wu W, Kirkpatrick J and
Kuhnert N: Profiling the chlorogenic acids and other caffeic acid
derivatives of herbal chrysanthemum by LC-MSn. J Agric
Food Chem. 55:929–936. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Lin LZ and Harnly JM: Identification of
the phenolic components of chrysanthemum flower (Chrysanthemum
morifolium Ramat). Food Chem. 120:319–326. 2010. View Article : Google Scholar
|
|
34.
|
Sudo H, Kodama HA, Amagai Y, Yamamoto S
and Kasai S: In vitro differentiation and calcification in a new
clonal osteogenic cell line derived from newborn mouse calvaria. J
Cell Biol. 96:191–198. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Bellows CG, Aubin JE and Heersche JN:
Initiation and progression of mineralization of bone nodules formed
in vitro: the role of alkaline phosphatase and organic phosphate.
Bone Miner. 14:27–40. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Domon S, Shimokawa H, Yamaguchi S and Soma
K: Temporal and spatial mRNA expression of bone sialoprotein and
type I collagen during rodent tooth movement. Eur J Orthod.
23:339–348. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Chen Y, Bal BS and Gorski JP: Calcium and
collagen binding properties of osteopontin, bone sialoprotein, and
bone acidic glycoprotein-75 from bone. J Biol Chem.
267:24871–24878. 1992.PubMed/NCBI
|
|
38.
|
Khosla S: Minireview: the OPG/RANKL/RANK
system. Endocrinology. 142:5050–5055. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Yang L, Takai H, Utsunomiya T, Li X, Li Z,
Wang Z, Wang S, Sasaki Y, Yamamoto H and Ogata Y: Kaempferol
stimulates bone sialoprotein gene transcription and new bone
formation. J Cell Biochem. 110:1342–1355. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Takuwa Y, Ohse C, Wang EA, Wozney JM and
Yamashita K: Bone morphogenetic protein-2 stimulates alkaline
phosphatase activity and collagen synthesis in cultured
osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun.
174:96–101. 1991. View Article : Google Scholar
|
|
41.
|
Nakase T, Takaoka K, Masuhara K, Shimizu
K, Yoshikawa H and Ochi T: Interleukin-1β enhances and tumor
necrosis factor-α inhibits bone morphogenetic protein-2-induced
alkaline phosphatase activity in MC3T3-E1 osteoblastic
cells. Bone. 21:17–21. 1997.
|
|
42.
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Yao R and Cooper GM: Requirement for
phosphatidylinositol-3 kinase in the prevention of apoptosis by
nerve growth factor. Science. 267:2003–2006. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Franke TF, Kaplan DR and Cantley LC: PI3K:
Downstream AKTion blocks apoptosis. Cell. 88:435–437. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Choi EM: Honokiol protects osteoblastic
MC3T3-E1 cells against antimycin A-induced cytotoxicity. Inflamm
Res. 60:1005–1012. 2011. View Article : Google Scholar
|
|
46.
|
Zelko IN, Mariani TJ and Folz RJ:
Superoxide dismutase multigene family: a comparison of the CuZn-SOD
(SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures,
evolution, and expression. Free Radic Biol Med. 33:337–349. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Braun KF, Ehnert S, Freude T, Egaña JT,
Schenck TL, Buchholz A, Schmitt A, Siebenlist S, Schyschka L,
Neumaier M, Stöckle U and Nussler AK: Quercetin protects primary
human osteoblasts exposed to cigarette smoke through activation of
the anti-oxidative enzymes HO-1 and SOD-1. ScientificWorldJournal.
11:2348–2357. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Sun L, Zhang J, Lu X, Zhang L and Zhang Y:
Evaluation to the antioxidant activity of total flavonoids extract
from persimmon (Diospyros kaki L.) leaves. Food Chem
Toxicol. 49:2689–2696. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Yin H, Shi ZG, Yu YS, Hu J, Wang R, Luan
ZP and Guo DH: Protection against osteoporosis by statins is linked
to a reduction of oxidative stress and restoration of nitric oxide
formation in aged and ovariectomized rats. Eur J Pharmacol.
674:200–206. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Nojiri H, Saita Y, Morikawa D, Kobayashi
K, Tsuda C, Miyazaki T, Saito M, Marumo K, Yonezawa I, Kaneko K,
Shirasawa T and Shimizu T: Cytoplasmic superoxide causes bone
fragility owing to low-turnover osteoporosis and impaired collagen
cross-linking. J Bone Miner Res. 26:2682–2694. 2011. View Article : Google Scholar : PubMed/NCBI
|
